The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...

Bayer said on Tuesday it was preparing market launches this year of two new drugs that could each have annual peak sales of at least $1 billion, as it seeks to strengthen its pharmaceuticals business ...

A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...

A commonly used diabetes medication could improve long-term recovery for cancer patients, according to research from the University of East Anglia. Many cancer patients go on to develop heart ...

On Sunday, researchers announced that an experimental drug from Eli Lilly, lepodisiran, reduced levels of Lp (a) by a ...

When the heart’s main pumping chamber can’t contract with enough force, the entire body feels the effects. Recent medical advances have transformed treatment options, giving new hope to the ...

An expected delay in a key step in CK Hutchison's planned sale of its Panama ports to a U.S. group, a deal blasted by Chinese ...

Drugs from Novartis, Amgen and now Lilly have proven powerfully effective at reducing Lp(a). Whether that will translate to a ...

An intensive three-drug regimen of heart medications did not significantly impact the rate of serious cardiovascular events at five years in women who experienced signs and symptoms of ischemia ...

“Nearly a quarter of the world’s population has elevated levels of Lp (a), putting them at a significantly higher risk of cardiovascular events such as heart attacks and strokes,” said Steven Nissen, ...

Mar. 18, 2025 — Lifestyle and health factors that are linked with heart disease appear to have a greater impact on cardiovascular risk in women than ... Continued Medication Important for Heart ...